Mr Trask's previous role with Excel PharmaStudies, a China-based full service CRO, focused on the developing clinical research markets in China and Asia-Pacific.
Prior to Excel, he was director of blobal business activities at Evidence Clinical and Pharmaceutical Research where he launched business and clinical initiatives for this Russia-based CRO in the US, Europe and Asia.
Tony Richardson, CEO of Venn Life Sciences, said: “Dale's broad experience in CRO business relationships will make him an outstanding member of Venn's team. He will help ensure that our strategic business relationships continue to grow as we deliver competitive solutions to our pharmaceutical and biotech customers.”
Will Mr Trask's experience benefit the company?
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.
User Comments